Author | Gunter von Minckwitz, MD, PhD | OncLive

Author | Gunter von Minckwitz, MD, PhD

Articles

Dr. von Minckwitz on the Safety Profile of the APHINITY Trial for HER2+ Breast Cancer

July 07, 2017

Video

Gunter von Minckwitz, MD, PhD, president of the German Breast Group in Neu-Isenburg, Germany, discusses the safety profile of the phase III APHINITY trial for patients with HER2-positive breast cancer.

Dr. von Minckwitz on Phase III Results of the APHINITY Trial for Breast Cancer

June 06, 2017

Video

Gunter von Minckwitz, MD, PhD, president of the German Breast Group in Neu-Isenburg, Germany, discusses the phase III results of the APHINITY trial, which explored the addition of pertuzumab (Perjeta) to standard postoperative trastuzumab (Herceptin) therapy for patients with HER2-positive early breast cancer.

Dr. von Minckwitz on the Rationale of PENELOPE

January 23, 2014

Video

Gunter von Minckwitz, MD, PhD, Chairman, German Breast Group, Professor of Gynecology, University of Frankfurt, Germany, discusses the rationale behind the phase III PENELOPE trial.

Dr. von Minckwitz on Breast Cancer Responses

May 07, 2013

Video

Gunter von Minckwitz, MD, PhD, discusses the current unsolved medical situation regarding patients with breast cancer who do not respond to treatment.

x